4SC-202 has been used in trials studying the treatment of Advanced Hematologic Malignancies.
4SC-202 has been used in trials studying the treatment of Advanced Hematologic Malignancies.
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.